Blue Owl Capital Holdings »

Ww Intl shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Ww Intl (WW) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Ww Intl

Tip: Access up to 7 years of quarterly data

All positions including Ww Intl held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ww Intl by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 96k 13.74

More positions owned by Blue Owl Capital Holdings

Aktis Oncology (AKTS)
Larimar Therapeutics (LRMR)
Engene Holdings
Nuveen Churchill Direct Lend Com Shs (NCDL)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Maplight Therapeutics (MPLT)
Compass Therapeutics (CMPX)
Context Therapeutics (CNTX)
Holley (HLLY)
Eyepoint Com New (EYPT)
Corvus Pharmaceuticals (CRVS)
Conduent Incorporate (CNDT)
Ultragenyx Pharmaceutical (RARE)
Aquestive Therapeutics (AQST)

View all positions for Blue Owl Capital Holdings

Top funds holding Ww Intl

Cooper Creek Partners Management
Fund 1 Investments
Aristeia Capital
Millennium Management
Carronade Capital Management
UBS Group
Contrarius Group Holdings
BlackRock
AEGON USA Investment Management
Susquehanna International
Cygnus Capital Advisors
Guggenheim Capital, LLC Managers
Quinn Opportunity Partners
683 Capital Management
Balyasny Asset Management

View all funds holding Ww Intl